Relevance of flow cytometric enumeration of post-thaw leucocytes: influence of temperature during cell staining on viable cell recovery

Vox Sanguinis

Volumn 111, Issue 2, 2016, Pages 187-196

  Fritsch, G ^a   Frank, N ^a   Dmytrus, J ^a   Frech, C ^a   Pichler, H ^a   Witt, V ^a   Geyeregger, R ^a   Scharner, D ^a   Trbojevic, D ^a   Zipperer, E ^a   Printz, D ^a   Worel, N ^b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

cell loss; cell recovery; cell viability; CryoStor CS10; DMSO; post thaw cell enumeration

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL COUNTING; CELL STAINING; CELL VIABILITY; CLINICAL ARTICLE; CRYOPRESERVATION; FEMALE; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; LEUKOCYTE; MALE; MULTIPLE MYELOMA; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STAINING; TEMPERATURE; THAWING;

EID: 84981203342     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12398     Document Type: Article

References (21)

1. Gratama JW, Kraan J, Keeney M, et al.: Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy 2003; 5:55–65
2. Keeney M, Chin-Yee I, Weir K, et al.: Single platform flow cytometric absolute CD34 + cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998; 34:61–70
3. Moroff G, Eichler H, Brand A, et al.: Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion 2006; 46:507–515
4. Spellman S, Hurley CK, Brady C, et al.: Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood. Cytotherapy 2011; 13:848–855
5. D'Rozario J, Parisotto R, Stapleton J, et al.: Pre infusion, post thaw CD34 + peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantation. Transfus Apher Sci 2014; 50:443–450
6. Yang H, Acker JP, Cabuhat M, et al.: Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation. Bone Marrow Transplant 2003; 32:1021–1026
7. Clarke DM, Yadock DJ, Nicoud IB, et al.: Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution. Cytotherapy 2009; 11:472–479
8. Nicoud IB, Clarke DM, Taber G, et al.: Cryopreservation of umbilical cord blood with a novel freezing solution that mimics intracellular ionic composition. Transfusion 2012; 52:2055–2062
9. Stylianou J, Vowels M, Hadfield K: Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB. Cytotherapy 2006; 8:57–61
10. Fritsch G, Witt V, Matthes S, et al.: Improved Post-Thaw Stability Validation of Peripheral Blood Cell Products Utilizing the Intracellular-Like Cryostor Cryopreservation Solution, and Preliminary Results of Clinical Application. Biol Blood Marrow Transplant 2011; 17:210–211
11. Purtill D, Smith K, Devlin S, et al.: Dominant unit CD34 + cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice. Blood 2014; 124:2905–2912
12. de Boer F, Drager AM, Pinedo HM, et al.: Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002; 29:249–255
13. Allan DS, Keeney M, Howson-Jan K, et al.: Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29:967–972
14. Castelhano MV, Reis-Alves SC, Vigorito AC, et al.: Quantifying loss of CD34 + cells collected by apheresis after processing for freezing and post-thaw. Transfus Apher Sci 2013; 48:241–246
15. Reich-Slotky R, Colovai AI, Semidei-Pomales M, et al.: Determining post-thaw CD34 + cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity. Vox Sang 2008; 94:351–357
16. Fritsch G, Witt V, Spengler HP, et al.: Robust multi-parameter single-platform quantification of myeloid and B-lymphoid CD34 progenitor cells in all clinical CD34 cell sources and in thawed PBSC. Pediatr Hematol Oncol 2012; 29:595–610
17. Hayakawa J, Joyal EG, Gildner JF, et al.: 5% dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO. Transfusion 2010; 50:2158–2166
18. Yang H, Zhao H, Acker JP, et al.: Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45 + and CD34 + cells of umbilical cord blood and mobilized peripheral blood. Cryobiology 2005; 51:165–175
19. Goodwin HS, Grunzinger LM, Regan DM, et al.: Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential. Cytotherapy 2003; 5:80–86
20. Lee HR, Shin S, Yoon JH, et al.: Attached Segment Has Higher CD34(+) Cells and CFU-GM Than the Main Bag After Thawing. Cell Transplant 2015; 24:305–310
21. Lee S, Kim S, Kim H, et al.: Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation. Vox Sang 2008; 94:146–152